GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC
Abroad (travel likely)Active Not RecruitingPHASE1, PHASE2
Conditions
HCC
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Johns Hopkins Hospital, Baltimore, Maryland, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Auckland Clinical Studies, Auckland, New Zealand